Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 300

1.

Maturity Related Differences in Body Composition Assessed by Classic and Specific Bioimpedance Vector Analysis among Male Elite Youth Soccer Players.

Toselli S, Marini E, Maietta Latessa P, Benedetti L, Campa F.

Int J Environ Res Public Health. 2020 Jan 22;17(3). pii: E729. doi: 10.3390/ijerph17030729.

2.

Nanoscale subcellular architecture revealed by multicolor three-dimensional salvaged fluorescence imaging.

Zhang Y, Schroeder LK, Lessard MD, Kidd P, Chung J, Song Y, Benedetti L, Li Y, Ries J, Grimm JB, Lavis LD, De Camilli P, Rothman JE, Baddeley D, Bewersdorf J.

Nat Methods. 2020 Jan 6. doi: 10.1038/s41592-019-0676-4. [Epub ahead of print]

PMID:
31907447
3.

Integrated ecological modelling for evidence-based determination of water management interventions in urbanized river basins: Case study in the Cuenca River basin (Ecuador).

Jerves-Cobo R, Benedetti L, Amerlinck Y, Lock K, De Mulder C, Van Butsel J, Cisneros F, Goethals P, Nopens I.

Sci Total Environ. 2019 Dec 16;709:136067. doi: 10.1016/j.scitotenv.2019.136067. [Epub ahead of print]

PMID:
31869707
4.

Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study.

Gastaldi M, Mariotto S, Giannoccaro MP, Iorio R, Zoccarato M, Nosadini M, Benedetti L, Casagrande S, Di Filippo M, Valeriani M, Ricci S, Bova S, Arbasino C, Mauri M, Versino M, Vigevano F, Papetti L, Romoli M, Lapucci C, Massa F, Sartori S, Zuliani L, Barilaro A, De Gaspari P, Spagni G, Evoli A, Liguori R, Ferrari S, Marchioni E, Giometto B, Massacesi L, Franciotta D.

Eur J Neurol. 2019 Dec 8. doi: 10.1111/ene.14139. [Epub ahead of print]

PMID:
31814224
5.

The Role of Somatic Maturation on Bioimpedance Patterns and Body Composition in Male Elite Youth Soccer Players.

Campa F, Silva AM, Iannuzzi V, Mascherini G, Benedetti L, Toselli S.

Int J Environ Res Public Health. 2019 Nov 26;16(23). pii: E4711. doi: 10.3390/ijerph16234711.

6.

Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.

Cortese A, Lombardi R, Briani C, Callegari I, Benedetti L, Manganelli F, Luigetti M, Ferrari S, Clerici AM, Marfia GA, Rigamonti A, Carpo M, Fazio R, Corbo M, Mazzeo A, Giannini F, Cosentino G, Zardini E, Currò R, Gastaldi M, Vegezzi E, Alfonsi E, Berardinelli A, Kouton L, Manso C, Giannotta C, Doneddu P, Dacci P, Piccolo L, Ruiz M, Salvalaggio A, De Michelis C, Spina E, Topa A, Bisogni G, Romano A, Mariotto S, Mataluni G, Cerri F, Stancanelli C, Sabatelli M, Schenone A, Marchioni E, Lauria G, Nobile-Orazio E, Devaux J, Franciotta D.

Neurol Neuroimmunol Neuroinflamm. 2019 Nov 21;7(1). pii: e639. doi: 10.1212/NXI.0000000000000639. Print 2020 Jan.

7.

Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years.

Benedetti L, Garnero M, Demichelis C, Grandis M, Briani C, Beltramini S, Bellucci M, Prada V, Massa F, Gastaldi M, Schenone A, Franciotta D.

J Neuroimmunol. 2019 Dec 15;337:577081. doi: 10.1016/j.jneuroim.2019.577081. Epub 2019 Oct 15.

PMID:
31677562
8.

Identification of non-cancer cells from cancer transcriptomic data.

Bortolomeazzi M, Keddar MR, Ciccarelli FD, Benedetti L.

Biochim Biophys Acta Gene Regul Mech. 2019 Oct 22:194445. doi: 10.1016/j.bbagrm.2019.194445. [Epub ahead of print] Review.

PMID:
31654804
9.

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.

Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group.

Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4.

PMID:
31610404
10.

Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.

Verboon C, van den Berg B, Cornblath DR, Venema E, Gorson KC, Lunn MP, Lingsma H, Van den Bergh P, Harbo T, Bateman K, Pereon Y, Sindrup SH, Kusunoki S, Miller J, Islam Z, Hartung HP, Chavada G, Jacobs BC, Hughes RAC, van Doorn PA; IGOS Consortium.

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):113-121. doi: 10.1136/jnnp-2019-321496. Epub 2019 Oct 5.

PMID:
31586949
11.

Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study.

Prada V, Massa F, Salerno A, Fregosi D, Beronio A, Serrati C, Mannironi A, Mancardi G, Schenone A, Benedetti L.

Neurol Sci. 2019 Oct 4. doi: 10.1007/s10072-019-04077-x. [Epub ahead of print]

PMID:
31586288
12.

Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis.

Cassano M, Biressi S, Finan A, Benedetti L, Omes C, Boratto R, Martin F, Allegretti M, Broccoli V, Cusella De Angelis G, Comoglio PM, Basilico C, Torrente Y, Michieli P, Cossu G, Sampaolesi M.

PLoS One. 2019 Jul 24;14(7):e0220357. doi: 10.1371/journal.pone.0220357. eCollection 2019.

13.

"Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?"

Lapucci C, Benedetti L, Tavarelli C, Serrati C, Godani M, Schenone A, Franciotta D.

Clin Neurol Neurosurg. 2019 Sep;184:105424. doi: 10.1016/j.clineuro.2019.105424. Epub 2019 Jul 12.

PMID:
31330415
14.

Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database.

Doneddu PE, Bianchi E, Cocito D, Manganelli F, Fazio R, Filosto M, Mazzeo A, Cosentino G, Cortese A, Jann S, Clerici AM, Antonini G, Siciliano G, Luigetti M, Marfia GA, Briani C, Lauria G, Rosso T, Cavaletti G, Carpo M, Benedetti L, Beghi E, Liberatore G, Santoro L, Peci E, Tronci S, Cotti Piccinelli S, Toscano A, Piccolo L, Verrengia EP, Leonardi L, Schirinzi E, Mataluni G, Ruiz M, Dacci P, Nobile-Orazio E; Italian CIDP Database Study Group.

Eur J Neurol. 2020 Jan;27(1):136-143. doi: 10.1111/ene.14044. Epub 2019 Aug 9.

PMID:
31325350
15.

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.

Mourikis TP, Benedetti L, Foxall E, Temelkovski D, Nulsen J, Perner J, Cereda M, Lagergren J, Howell M, Yau C, Fitzgerald RC, Scaffidi P; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Ciccarelli FD.

Nat Commun. 2019 Jul 15;10(1):3101. doi: 10.1038/s41467-019-10898-3.

16.

Current treatment practice of Guillain-Barré syndrome.

Verboon C, Doets AY, Galassi G, Davidson A, Waheed W, Péréon Y, Shahrizaila N, Kusunoki S, Lehmann HC, Harbo T, Monges S, Van den Bergh P, Willison HJ, Cornblath DR, Jacobs BC; IGOS Consortium.

Neurology. 2019 Jul 2;93(1):e59-e76. doi: 10.1212/WNL.0000000000007719. Epub 2019 Jun 7.

PMID:
31175208
17.

Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis.

Genet G, Boyé K, Mathivet T, Ola R, Zhang F, Dubrac A, Li J, Genet N, Henrique Geraldo L, Benedetti L, Künzel S, Pibouin-Fragner L, Thomas JL, Eichmann A.

Nat Commun. 2019 May 28;10(1):2350. doi: 10.1038/s41467-019-10359-x.

18.

Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis?

Lapucci C, Boffa G, Massa F, Franciotta D, Castelletti L, Uccelli A, Morbelli S, Nobili F, Benedetti L, Roccatagliata L.

Eur J Neurol. 2019 Oct;26(10):e86-e87. doi: 10.1111/ene.13977. Epub 2019 May 17. No abstract available.

PMID:
31099961
19.

High throughput measure of diversity in cytoplasmic and nuclear traits for unravelling geographic distribution of rosemary.

Nunziata A, De Benedetti L, Marchioni I, Cervelli C.

Ecol Evol. 2019 Mar 18;9(7):3728-3739. doi: 10.1002/ece3.4998. eCollection 2019 Apr.

20.

Are basketball players more likely to develop Hirayama disease?

Cabona C, Beronio A, Martinelli I, Briani C, Lapucci C, Serrati C, Delucchi S, Mannironi A, Benedetti L.

J Neurol Sci. 2019 May 15;400:142-144. doi: 10.1016/j.jns.2019.03.020. Epub 2019 Mar 21.

PMID:
30951991

Supplemental Content

Loading ...
Support Center